IBO · Impact Biomedical Inc.
$0.43
0.00 (-0.46%)
At close · Jul 28
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As reflected in the accompanying financial statements the Company has incurred operating losses as well as negative cash flows from operating activities over the past two years. These factors raise substantial doubt about the Company's ability to continue as a going concern within one year of the date that the financial statements are issued.”View the 10-Q filed May 12, 2026
Market Cap
$46.36M
Shares
107.82M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Mark Suseck | COO | $158,689 |
| Frank D. Heuszel | CEO | $54,806 |
| Todd D. Macko | CFO | $555 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Mark Suseck | COO | — |
| Todd D. Macko | CFO | — |
| Frank D. Heuszel | CEO | — |